Deletion of Endothelial Transforming Growth Factor-β Signaling Leads to Choroidal Neovascularization

Anja Schlecht1, Sarah V Leimbeck1, Herbert Jägle2

  • 1Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany.

Insights

Transforming growth factor-beta (TGF-β) signaling impairment in eye vascular endothelial cells triggers choroidal neovascularization (CNV). This finding is crucial for understanding vision loss in age-related macular degeneration.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Choroidal neovascularization (CNV) is a key factor in vision loss associated with age-related macular degeneration (AMD).
  • The precise molecular mechanisms driving CNV pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of transforming growth factor-beta (TGF-β) signaling in the development of CNV.
  • To determine which ocular cell types are critical for TGF-β signaling in CNV formation.

Main Methods:

  • Generation of conditional knockout mouse models with targeted deletion of TGF-β signaling in the entire eye, retinal pigment epithelium (RPE), or vascular endothelium.
  • Induction of CNV and subsequent histological and functional analysis of retinal and RPE alterations.

Main Results:

  • Conditional deletion of TGF-β signaling in the entire eye induced CNV in both newborn and adult mice.
  • CNV areas exhibited photoreceptor degeneration, RPE changes, basal lamina deposits, and inflammatory cell infiltration.
  • Specific deletion of TGF-β signaling in vascular endothelial cells, but not RPE cells, was sufficient to cause CNV and associated retinal pathology.

Conclusions:

  • Impairment of TGF-β signaling in ocular vascular endothelium is sufficient to initiate CNV.
  • TGF-β signaling plays a fundamental role in the pathogenesis of ocular neovascularization and AMD.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K